These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19097802)
1. Photodynamic therapy with aluminum-chloro-phthalocyanine induces necrosis and vascular damage in mice tongue tumors. Longo JP; Lozzi SP; Simioni AR; Morais PC; Tedesco AC; Azevedo RB J Photochem Photobiol B; 2009 Feb; 94(2):143-6. PubMed ID: 19097802 [TBL] [Abstract][Full Text] [Related]
2. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS; Brasseur N; La Madeleine C; van Lier JE Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717 [TBL] [Abstract][Full Text] [Related]
3. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes. Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse. Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818 [TBL] [Abstract][Full Text] [Related]
5. Effects of photodynamic therapy mediated by nanoemulsion containing chloro-aluminum phthalocyanine: a histologic and immunohistochemical study in human gingiva. de Moraes M; de Vasconcelos RC; Longo JP; Muehlmann LA; de Azevedo RB; Lemos TM; Costa Ade L Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):592-7. PubMed ID: 26521145 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic process induced by chloro-aluminum phthalocyanine nanoemulsion in glioblastoma. Castilho-Fernandes A; Lopes TG; Primo FL; Pinto MR; Tedesco AC Photodiagnosis Photodyn Ther; 2017 Sep; 19():221-228. PubMed ID: 28599959 [TBL] [Abstract][Full Text] [Related]
7. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo. Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373 [TBL] [Abstract][Full Text] [Related]
8. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Brasseur N; Ouellet R; La Madeleine C; van Lier JE Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394 [TBL] [Abstract][Full Text] [Related]
9. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin. Margaron P; Madarnas P; Quellet R; Van Lier JE Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of pigmented choroidal melanomas. Gonzalez VH; Hu LK; Theodossiadis PG; Flotte TJ; Gragoudas ES; Young LH Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):871-8. PubMed ID: 7706035 [TBL] [Abstract][Full Text] [Related]
11. Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy. Vittar NB; Prucca CG; Strassert C; Awruch J; Rivarola VA Int J Biochem Cell Biol; 2008; 40(10):2192-205. PubMed ID: 18440266 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy using chloro-aluminum phthalocyanine decreases inflammatory response in an experimental rat periodontal disease model. de Moraes M; Vasconcelos RC; Longo JP; Muehlmann LA; de Azevedo RB; de Araújo Júnior RF; Araujo AA; de Lisboa Lopes Costa A J Photochem Photobiol B; 2017 Feb; 167():208-215. PubMed ID: 28086121 [TBL] [Abstract][Full Text] [Related]
13. In vivo photodynamic inactivation of Candida albicans using chloro-aluminum phthalocyanine. Carmello JC; Alves F; Ribeiro A; Basso FG; de Souza Costa CA; Tedesco AC; Primo FL; Mima EG; Pavarina AC Oral Dis; 2016 Jul; 22(5):415-22. PubMed ID: 26914185 [TBL] [Abstract][Full Text] [Related]
15. Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogs. Borgatti-Jeffreys A; Hooser SB; Miller MA; Lucroy MD Am J Vet Res; 2007 Apr; 68(4):399-404. PubMed ID: 17397295 [TBL] [Abstract][Full Text] [Related]
16. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Chan WS; Marshall JF; Lam GY; Hart IR Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641 [TBL] [Abstract][Full Text] [Related]
17. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Camerin M; Magaraggia M; Soncin M; Jori G; Moreno M; Chambrier I; Cook MJ; Russell DA Eur J Cancer; 2010 Jul; 46(10):1910-8. PubMed ID: 20356732 [TBL] [Abstract][Full Text] [Related]
18. The relationship of phthalocyanine 4 (pc 4) concentrations measured noninvasively to outcome of pc 4 photodynamic therapy in mice. Bai L; Guo J; Bontempo FA; Eiseman JL Photochem Photobiol; 2009; 85(4):1011-9. PubMed ID: 19320848 [TBL] [Abstract][Full Text] [Related]
19. Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma. Stukavec J; Horak L; Duchac V; Jirasek T; Rakusan J; Karaskova M; Pouckova P Neoplasma; 2008; 55(2):127-9. PubMed ID: 18237250 [TBL] [Abstract][Full Text] [Related]
20. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]